(Q34511403)

2 August 2017

1 reference

title

Prevention of acute renal failure in the critically ill. (English)

1 reference

2 August 2017

Clay A Block

1

1 reference

PubMed ID

11818313

2 August 2017

Harold L Manning

series ordinal

2

1 reference

PubMed ID

11818313

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

165

1 reference

2 August 2017

3

1 reference

2 August 2017

320-324

1 reference

Interventions in clinical acute renal failure: what are the data?

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

The effects of norepinephrine on hemodynamics and renal function in severe septic shock states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Amphotericin B nephrotoxicity in humans decreased by salt repletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.3.2106086

10.1164/AJRCCM.165.3.2106086

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11818313